Regulation (EU) 2015/1011
Commission Delegated Regulation (EU) 2015/1011 of 24 April 2015 supplementing Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors, and repealing Commission Regulation (EC) No 1277/2005 (Text with EEA relevance)
In forceTyperegulationDate24 Apr 2015Since15 Nov 2015Articles15Versions held69Cited by19 documentsLast changed27 Jun 2015
- 1Subject matter
- 2Definitions
- 3Conditions for granting licences
- 4Cases where a licence is not required
- 5Conditions for granting registrations
- 6Cases where a registration is not required
- 7Conditions for exemptions from certain requirements
- 8Criteria for determining the licit purposes of a transaction
- 9Information required to monitor trade
- 10Conditions for determining the lists of the countries of destination for exports of scheduled substances of
- 11Criteria for determining simplified procedures for pre-export notifications
- 12Criteria for determining simplified procedures for export authorisations
- 13Conditions and requirements concerning the information to be provided on the implementation of the monitori
- 14Repeal
- 15
- ANNEX I
- ANNEX II
- ANNEX III
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).